Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System

Research output: Chapter in Book/Report/Conference proceedingChapterScientificpeer-review

7 Downloads (Pure)

Abstract

We study the perceived value derived from data sharing activities by the representatives of a Nordic pharmaceutical company in the introduction of the European Medicines Verification System (EMVS). The system is an end-to-end verification protocol that would potentially enable the pharmaceutical companies to access the sales-point data from within the system, while maintaining the control of their own data. The benefits of the system are most notably in developing data sharing with the wholesalers and end-customers. Development of data sharing practices might enable more transparent logistics, and more targeted services and products.

Original languageEnglish
Title of host publicationThe Importance of Health Informatics in Public Health during a Pandemic
PublisherIOS PRESS
Pages276-279
Number of pages4
ISBN (Electronic)978-1-64368-093-4
ISBN (Print)978-1-64368-092-7
DOIs
Publication statusPublished - 26 Jun 2020
MoE publication typeA3 Part of a book or another research book

Publication series

NameStudies in Health Technology and Informatics
PublisherIOS PRESS
Volume272
ISSN (Print)0926-9630

Keywords

  • Data Sharing
  • European Medicines Verification System
  • Pharmaceutical Industry
  • Supply Chains

Fingerprint Dive into the research topics of 'Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System'. Together they form a unique fingerprint.

  • Cite this

    Levänen, L., Halminen, O., Tenhunen, H., & Seppälä, T. (2020). Data Sharing in Pharmaceutical Supply Chains - Case European Medicines Verification System. In The Importance of Health Informatics in Public Health during a Pandemic (pp. 276-279). (Studies in Health Technology and Informatics; Vol. 272). IOS PRESS. https://doi.org/10.3233/SHTI200548